NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells

Margaret A Nagai-Singer1, Holly A Morrison1, Mackenzie K Woolls1

  • 1Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, United States.

Frontiers in Oncology
|June 21, 2023
PubMed

Insights

NLRX1 suppresses pancreatic cancer progression by reducing cell proliferation and migration. This pattern recognition receptor also limits energy production and enhances cell death, revealing its tumor-suppressive role.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Pancreatic cancer is a lethal disease with few effective treatments.
  • NLRX1, a Nod-like Receptor (NLR), influences biological processes relevant to pancreatic cancer.
  • NLRX1's role in cancer is debated, with evidence suggesting both tumor promotion and suppression.

Purpose of the Study:

  • To investigate the function of NLRX1 in pancreatic cancer.
  • To clarify the dual roles of NLRX1 in cancer development and progression.

Main Methods:

  • Utilized gain-of-function and loss-of-function studies in murine Pan02 cells.
  • Performed transcriptomics analysis to identify affected signaling pathways.
  • Assessed cell death, proliferation, migration, reactive oxygen species production, and mitochondrial activity.

Main Results:

  • NLRX1 expression decreased pancreatic cancer cell proliferation, migration, and reactive oxygen species production.
  • NLRX1 increased susceptibility to cell death and reduced mitochondrial activity and energy production.
  • Transcriptomics revealed NLRX1 attenuates NF-κB, MAPK, AKT, and inflammasome signaling.

Conclusions:

  • NLRX1 exhibits tumor-suppressive functions in pancreatic cancer cells.
  • NLRX1 diminishes key cancer-associated biological functions, including proliferation and migration.
  • NLRX1 represents a potential therapeutic target for pancreatic cancer treatment.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K